Whole Human Genome Oligo Microarray Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment Compared to Healthy Controls.
Phase of Trial: Phase IV
Latest Information Update: 03 Mar 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacodynamics
- Sponsors Schering-Plough
- 06 Nov 2008 New trial record.